Delivery Order SPE2DR25D3803-SPE2DR26F3002
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens, with a contract ceiling value of $9,796.98 and an ultimate completion date of August 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,108.74 to supply Trulicity 1.5 mg/0.5 mL pens on a firm fixed price basis, with an ultimate completion date of September 3, 2025. This is a non-set-aside competitive award where the pharmaceutical distributor will fulfill the delivery order from its facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major healthcare solutions provider and pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,862.58 on August 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 12, 2025, and performance executed from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,868.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,610.71 for Trulicity 0.75 mg/0.5 mL pens on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete transaction under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The $2,437.92 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the...
- The Defense Logistics Agency (DLA) awarded a $26,276.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens. This is a non-set-aside competitive award with an ultimate completion date of June 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,181.03 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 4, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation and is scheduled for completion by August 5, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,186.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on October 17, 2025, with completion expected by October 20, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DR25D3803Indefinite Delivery Contract
- SPE2DR25D3803-SPE2DR26F3002Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $11,440.24. The contract, which was competitively awarded without set-aside designation, is firm fixed price and has an ultimate completion date of November 25, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion contract vehicle designated SPE2DX and extending through December 2026 that enables the supplier to provide a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts covering diverse pharmaceutical products including diabetes medications, neurological treatments, pain management drugs, antibiotics, vaccines, and specialized medical devices. The delivery order for Trulicity—a diabetes medication—represents a typical transaction within the company's ongoing relationship with DLA, demonstrating its established capability to fulfill federal medical supply requirements through open competition across multiple therapeutic domains and customer bases including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 11/23/25 |